These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2493531)

  • 1. Complement levels in septic primates treated with anti-C5a antibodies.
    Hangen DH; Stevens JH; Satoh PS; Hall EW; O'Hanley PT; Raffin TA
    J Surg Res; 1989 Mar; 46(3):195-9. PubMed ID: 2493531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates.
    Stevens JH; O'Hanley P; Shapiro JM; Mihm FG; Satoh PS; Collins JA; Raffin TA
    J Clin Invest; 1986 Jun; 77(6):1812-6. PubMed ID: 3711336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome.
    Weinberg PF; Matthay MA; Webster RO; Roskos KV; Goldstein IM; Murray JF
    Am Rev Respir Dis; 1984 Nov; 130(5):791-6. PubMed ID: 6497161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation in type 1 human diabetes.
    Sundsmo JS; Papin RA; Wood L; Hirani S; Waldeck N; Buckingham B; Kershnar A; Ascher M; Charles MA
    Clin Immunol Immunopathol; 1985 May; 35(2):211-25. PubMed ID: 3907907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man.
    Solomkin JS; Cotta LA; Satoh PS; Hurst JM; Nelson RD
    Surgery; 1985 Jun; 97(6):668-78. PubMed ID: 4002115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin-induced shock in the rat. A role for C5a.
    Smedegård G; Cui LX; Hugli TE
    Am J Pathol; 1989 Sep; 135(3):489-97. PubMed ID: 2789475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal complement complexes and anaphylatoxins in septic and ischemic patients.
    Heideman M; Norder-Hansson B; Bengtson A; Mollnes TE
    Arch Surg; 1988 Feb; 123(2):188-92. PubMed ID: 3277584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
    Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accentuated formation of the terminal C5b-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome.
    Langlois PF; Gawryl MS
    Am Rev Respir Dis; 1988 Aug; 138(2):368-75. PubMed ID: 3264125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension.
    Slotman GJ; Burchard KW; Williams JJ; D'Arezzo A; Yellin SA
    Surgery; 1986 Jun; 99(6):744-51. PubMed ID: 3520916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass.
    Tennenberg SD; Bailey WW; Cotta LA; Brodt JK; Solomkin JS
    Surgery; 1986 Aug; 100(2):134-42. PubMed ID: 3738745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator].
    Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S
    Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
    Gerard C; Hugli TE
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronological changes in the complement system in sepsis.
    Nakae H; Endo S; Inada K; Yoshida M
    Surg Today; 1996; 26(4):225-9. PubMed ID: 8727941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylatoxin generation in multisystem organ failure.
    Heideman M; Hugli TE
    J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylatoxin levels in human aqueous humor.
    Mondino BJ; Sumner H
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum complement levels and severity of sepsis.
    Nakae H; Endo S; Inada K; Takakuwa T; Kasai T; Yoshida M
    Res Commun Chem Pathol Pharmacol; 1994 May; 84(2):189-95. PubMed ID: 8091004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement and endotoxin-induced lung injury in sheep.
    Horn JK; Goldstein IM; Flick MR
    J Surg Res; 1984 May; 36(5):420-7. PubMed ID: 6374285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M; Bengtson A; Karlsson K; Heideman M
    Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.